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Abstract
We developed and characterized a mouse model of elevated intraocular pressure (IOP) to investigate the underlying cellular
and genetic mechanisms of retinal ganglion cell (RGC) death. IOP was unilaterally increased in C57BL/6J mice by photocoagu-
lation of the episcleral and limbal veins. IOP was measured using an indentation tonometer. RGC survival was measured by ret-
rograde labeling using DiI applied to the superior colliculous. The mechanism of RGC death was investigated using TUNEL
staining, immunostaining for cleaved caspase-3, and Western blot for Bcl-2 and Bax expression. RT-PCR was used to measure
changes in Bcl-2, Bax, Bad, Bak, P53, ICE and Fas. Mean IOP was increased in the treated eyes from 13 ± 1.8 to 20.0 ± 2.8
mm Hg at four weeks and 17 ± 2.2 mm Hg at eight weeks. RGC loss was 15.6 ± 3.4% at two weeks and 27.3 ± 4.5% at four weeks
after laser photocoagulation. TUNEL staining and caspase-3 positive cells were increased in the ganglion cell layer (GCL) in the
treated eyes and seldom found in the control eyes. Bcl-2 expression in control group was higher than in the experimental group,
while Bax expression in the control group was less than in experimental group. This mouse model resulted in a consistent, sus-
tained increase in IOP with a reduction in the number of RGCs in the treated eye. The RGCs in eyes with elevated IOP were
TUNEL-positive, with increased caspase-3 and decreased Bcl-2, consistent with apoptosis as the mechanism of neuronal cell
death.
 2004 Elsevier Ltd. All rights reserved.
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Primary open angle glaucoma (POAG) is the most
common form of glaucoma and the second leading
cause of blindness. POAG is deﬁned by characteristic
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E-mail address: rgross@bcm.tmc.edu (R.L. Gross).cupping, the loss of retinal ganglion cells (RGCs), and
the resulting functional defects of the visual ﬁeld. It
is widely accepted that although the level of intraocu-
lar pressure (IOP) is not the only risk factor, its inci-
dence, severity, and progression consistently correlate
with the occurrence of human glaucoma and reducing
IOP is the only currently available treatment for
decreasing the risk of progressive glaucomatous optic
nerve damage. Lowering IOP has been shown to be
eﬀective in preventing the occurrence of glaucoma in
ocular hypertensives (Kass, Heuer, & Higginbotham,
2002), and in glaucoma patients, eﬀective lowering of
IOP decreases the risk of progressive visual loss (AGIS,
2000).
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For this reason, animal models, including the monkey,
rat and rabbit, of elevated IOP have been developed to
investigate the mechanisms of glaucomatous damage
and strategies for therapeutic intervention. Gaasterland
and Kupfer (1974) described experimental IOP elevation
in monkeys using excessive direct application of argon
laser to the trabecular meshwork. Although anatomically
the closest model to human glaucoma, this model is lim-
ited by the expense involved and the high and variable
pressures obtained. Later, models of increased IOP in rats
were developed using various techniques to block aque-
ous egress from the eye. These included hyperosmotic
saline microinjection into limbal veins, cauterization of
the large veins draining the anterior segment, and abla-
tion of the limbal vessels with a laser to decrease outﬂow
(Mittag, Danias, & Pohorenec, 2000; Sawada &Neufeld,
1999; Shareef, Garcia-Valenzuela, & Salierno, 1995). The
mouse has been extensively studied in many experimental
ﬁelds because of the feasibility of using transgenic or
knockout technology, as well as the relative ease of han-
dling and relatively low cost when compared with other
mammals (John, Anderson, & Smith, 1999). Although
very useful in evaluating some eﬀects of elevated IOP,
concerns remain about mouse strains with elevated IOP
associated with anterior segment abnormalities in that
other eﬀects of these developmental changes could impact
ocular structures and processes (John, Smith, &
Savinova, 1998). Additionally, the elevated IOP occurs
between 6 and 12 months of age, making it less desirable
for use as amodel of elevated IOP as timing issuesmust be
considered (Danias, Lee, & Zamora, 2003a). This study
also showed that there appears to be RGC loss in C57/
BL6 non-glaucomatousmice, although it started between
12 and 15 months of age, making the RGC loss later and
less severe than inDBA/2mice with elevated IOP (Danias
et al., 2003a). This again demonstrates the need for an
acquiredmouse model where the IOP elevation will occur
early and predictably. Currently, nothing is known con-
cerning the manifestations of RGC death in the presence
of elevated IOP in the mouse.
1.2. Measurement of IOP in mice
It is therefore highly desirable to develop a mouse
model of elevated IOP in wild-type animals for glau-
coma research. A major obstacle for developing an ele-
vated IOP wild-type mouse model has been that the
globe of the mouse is small. Standard techniques to
non-invasively measure IOP using available tonometers
are not possible, and thus previous eﬀorts to raise IOP
in mouse eyes could not easily be evaluated. Invasive
tonometers were developed to measure the IOP in mice
by micropipette (Avila, Carre, & Stone, 2001), glassmicroneedle (John, Hagaman, MacTaggart, Peng, &
Smithes, 1997), or microneedle (Aihara, Lindsey, &
Weinreb, 2003). These techniques have the advantage
of directly measuring IOP, but the impact of punctur-
ing the globe on the disease process and the impact
on repetitive measurements is not fully understood. Re-
cently, non-invasive IOP measuring devices have been
developed including a modiﬁed Goldmann applanation
tonometer (Cohan & Bohr, 2001) and a plunger device
(Danias, Kontiola, Filippopoulos, & Mittag, 2003b).
Moreover, our lab has developed an indentation-type
tonometer that can reliably measure mouse IOP. With
this IOP measuring device, it is now possible to develop
and characterize a mouse model of elevated IOP for
studying genetic factors that are related to the causa-
tion, prevention and treatment of human glaucoma.
A recent report of an alternative method of elevating
IOP in mice using laser to induce angle-closure also
demonstrated elevated IOP with a reduction of optic
nerve cross-sectional area, mean axon density, and total
number of axons in the treated eyes at 12 weeks post-
treatment. This technique requires perforation of the
cornea to ﬂatten the anterior chamber prior to laser
application (Mabuchi, Aibara, & Mackey, 2003).
Another model involves the injection of indocyanine
green in the anterior chamber in conjunction with diode
laser application that found changes in the ERG in eyes
with elevated IOP (Grozdanic, Betts, & Sakaguchi,
2003). Both of these models require perforation of the
cornea that could potentially lead to ﬁndings related
to the technique rather than the elevated IOP and addi-
tionally could aﬀect subsequent non-invasive IOP
measurement.
In this study, we developed an elevated IOP mouse
model by argon laser photocoagulation of the episcleral
and limbal veins of one eye, and monitoring the IOP of
both eyes with this indentation-type tonometer. In order
to evaluate whether it may represent a viable mouse
model for human glaucoma, we carried out a series of
experiments to assess the pathological changes of the
photocoagulated eyes and evaluate apoptosis as a possi-
ble mechanism of RGC death in this mouse model of
elevated IOP.2. Materials and methods
All experiments were conducted and all laboratory
animals were treated in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vi-
sion Research and approved by the Baylor College of
Medicine Animal and Use Committee. Animals were
housed under a 12-h light–12-h dark cycle with standard
chow and water.
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Experimental elevation of IOP was induced unilater-
ally in 12 C57BL/6J mice, age <5 weeks. Approximately
80% of the mice used were female. For all experiments,
the untreated right eyes served as the controls for the
treated left eyes. Animals were anesthetized with intra-
peritoneal injection of ketamine (50 mg/kg) and xylazine
(5 mg/kg) and placed on warming pads throughout the
procedure. One eye of each animal underwent argon
laser photocoagulation of the episcleral and limbal
veins. A spot size of 50 lm, duration of 0.1 s, and power
of 80–110 mW were applied to the visible vasculature
within 1 mm of the limbus over 290 degrees and 15–20
spots on each episcleral vein using green-only argon
laser (Coherent, CA). The corneas were moistened with
balanced salt solution as needed throughout the
procedure.
2.2. IOP measurement in a chronic glaucoma model
2.2.1. Indentation tonometer
A modiﬁed Schiotz-like indentation tonometer was
designed and manufactured using aluminum for the
platform, stainless steel for the base, and Teﬂon-coated
titanium for the plunger (Carbtex Corporation, Hou-
ston, TX). The plunger weighed 253.1 mg with tip diam-
eter of 809 lm and contact area of 0.514 mm. The
tonometer was mounted on a micro-manipulator to ena-
ble vertical and horizontal excursions (Fig. 1).
2.3. Pressure calibration
Adult C57BL/6J mice were killed by an overdose of
anesthesia with intraperitoneal injection of ketamine
and xylazine and the eyes were removed. Immediately,Fig. 1. Indentation tonometer measuring the IOP in a live mouse. A
modiﬁed Schiotz-like indentation tonometer with an aluminum plat-
form, a stainless steel base, and a Teﬂon-coated titanium for the
plunger. The plunger weighed 253.1 mg with tip diameter of 809 lm
and contact area of 0.514 mm2. The tonometer was mounted on a
micro-manipulator to enable vertical and horizontal excursions.to minimize any changes in tissue integrity, the mounted
globe was cannulated with a sterile, 28-gauge needle
through the optic nerve to prevent distortion of the
globe anteriorly and to prevent any leakage from
around the needle. Resistance was excessive with smaller
bore needles or micropipettes such that reliable trans-
ducer outputs could not be consistently obtained. The
needle was connected to a pressure transducer with a
signal ampliﬁer (model 90602; SpaceLabs, Inc.; Red-
mond, WA) and balanced salt solution (BSS) hanging
on an intravenous (IV) pole. Actual IOP was read from
the digital readout of the pressure transducer. IOP was
varied and maintained at a given pressure by altering
the height of the IV pole. This closed system was ﬁlled
with BSS and all air bubbles were removed before
cannulation.
2.4. Tonometer calibration
A single drop of BSS, using the 28-gauge needle on a
tuberculin syringe, was dropped onto the cornea prior to
the measurement of IOP. After the IOP was set at a
given level by altering the height of the BSS bottle on
the IV pole, the tonometer was slowly lowered onto
the mounted globe on the axis normal to the apex
of the central cornea until the ﬁrst contact with the
corneal surface was made. The position of the tono-
meter at the ﬁrst contact was noted using the microme-
ter scale on the micro-manipulator. The tonometer was
then further lowered until the upward movement of the
tonometer tip was ﬁrst noted. The position of the
tonometer at the ﬁrst upward movement of the tono-
meter tip was noted using the micrometer scale on the
micro-manipulator. By subtracting the two positions
noted on the scale of the micro-manipulator, total
excursion of the tonometer was calculated. The entire
procedure was performed under direct visualization
using a vertically mounted microscope. The average of
two measurements was made at IOP each level.
Statistical analysis was performed on a computer
(Excel; Microsoft Corp., Redmond, WA). Known IOP
from the pressure transducer was plotted against the
excursion of the tonometer. Best-ﬁt logarithmic regres-
sion curve was derived to calculate correlation coeﬃ-
cients. Paired t-test was used to detect inter-animal
diﬀerences.
2.5. Non-invasive IOP measurement in live mice
After the mice were anesthetized using intraperitoneal
injection of ketamine (50 mg/kg) and xylazine (5 mg/kg),
they were placed on a stainless steel platform and gently
immobilized using head and tail holders. Body tempera-
ture was maintained using a gentle heating lamp. BSS
was placed on the eye to prevent corneal dehydration
172 J. Ji et al. / Vision Research 45 (2005) 169–179and to facilitate visualization. The mouse was placed in
a holding device that was rotated in all three axes to al-
low the apex of the cornea to be normal to the vertically
mounted tonometer tip for each eye to be measured.
The tonometer tip was lowered onto the cornea and
the excursion of the tonometer was measured using the
method described above. All the procedures were per-
formed under visual control using vertically-mounted
microscope. Under direct microscopic observation, no
posterior movement of the globe, representing retropul-
sion of the globe into the orbit, could be detected until
the end point of the measurement. This is likely a result
of the very light-weight titanium plunger weighing only
253.1 mg. The mean of ﬁve consecutive measurements
was used. IOPs were measured prior to laser treatment,
and at least weekly thereafter.
2.6. Ganglion cell retrograde labeling and cell counting
Two days before the animals were sacriﬁced, the
RGCs were retrogradely labeled by the ﬂuorescent tra-
cer 1,1 0-dioctadecy1-3,3,3 03 0-tetramethylindocarbocya-
nine perchlorate (DiI), (Molecular Probes, Eugene,
OR) as a 10% solution in dimethylformamide, using pre-
viously described techniques that involve the application
of the tracer to the superior colliculi (SC) (Simon,
Roskies, & OLeary, 1994). In brief, the mice were anes-
thetized, each midbrain was exposed, and after remov-
ing the pia overlying the SC, DiI was introduced by
pressure injection with a Picospritzer II (General Valve,
Fairﬁeld, NJ) through a glass micropipette (tip internal
diameter, 50 lm), which was inserted into the SC.
Mice were sacriﬁced two and four weeks after laser pho-
tocoagulation. Whole mounted retinas were examined
under a confocal microscope. Specimens 2 and 4 mm
from the optic disc were photographed in the four reti-
nal quadrants. The number of DiI-labeled cells was
counted in the photographs and the density of labeled
RGCs/mm2 was calculated by averaging the eight counts
in each retina.
2.7. TUNEL staining for retinal sections
Retinas prepared for TUNEL staining and analysis
were divided into three groups: (1) non-laser-treated eyes
served as control; (2 and 3) laser-treated animals sacri-
ﬁced at two weeks and four weeks after laser. Both eyes
of all animals were enucleated and retinas were dissected
free and ﬁxed in 4% paraformaldehyde for 1 h. Retinal
sections were washed three times in PBS (pH = 7.4).
Flat-mounted retinas were cut transversely along the
superior–inferior axis of the globe to ensure comparabil-
ity. The sections were permeabilized in 0.1% Triton
X-100 and 0.1% sodium citrate solution for 5 min fol-
lowed by blocking in 3% H2O2 for 15 min. Sections were
incubated in TUNEL reaction mixture solution (Enzymesolution and label solution, Roche, Germany) overnight
at room temperature. Slides were rinsed three times in
PBS for 5 min each. Sections were then evaluated under
the confocal microscope.
2.8. Immunostaining for cleaved caspase-3
Paraﬃn retinal sections were divided into two groups:
control eyes; and laser-treated with elevated IOP at two
weeks. Retinal sections were washed in PBS (pH = 7.4),
incubated in blocking buﬀer (2% normal Goat serum
and 0.2% Triton X-100 in PBS) for 1 h, and incubated
in Cleaved caspase-3 FITC conjugated antibody (1:100,
Cell Signaling Technology, England) for 24 h at 4 C.
The sections were washed three times in PBS. The sec-
tions were evaluated under confocal microscopy.
2.9. Western blot for Bcl-2 and Bax expression
In order to quantify the factors known to modulate
apoptosis, after laser treatment western blots were used
to analyze the protein expression in the retinas. Fresh
retinal tissue from control and treated eyes were ex-
tracted and homogenized in Tris–HCl 25 mM buﬀer
consisting of 0.32 M sucrose, 1 mM EDTA, protease
and phosphatase inhibitor cocktails (Sigma, MO). Ly-
sates were centrifuged and the resulting supernatants
were collected and protein concentrations were deter-
mined by BCA assay. Samples were mixed with sample
buﬀer, heated at 99 C for 5 min, and 100 lg of total
protein was loaded onto 15% SDS–polyacrylamide gel
for eletrophoresis and staining.
For immunoblotting analysis, proteins were trans-
ferred onto nitrocellulose membranes. A blocking buﬀer
of Tris-base, 0.1% Tween 20 containing 5% non-fat
powdered milk was used for all incubations. Blots were
probed for 2 h at room temperature with primary anti-
body (1:100, Bcl-2; 1:500, Bax; 1:500, b-actin; 1:1000).
Blots were rinsed three times for 10 min each in TBST,
and were incubated for 1 h at room temperature with
HRP-conjugated IgG (Goat anti-Rabbit for Bcl-2 and
Bax, 1:2000, Cell Signaling Technology, England; Goat
anti-mouse for b-actin, Sigma, America). Membranes
were washed in TBST and immunoreactive proteins
were detected using the enhanced chemiluminescence
method (ECL, Amersham).
2.10. RNA isolation and semi-quantitative RT-PCR
Total RNA was isolated from retinas by acid guani-
dium thiocyanate–phenol–chloroform extraction using
a previously described method (Li & Tseng, 1995). The
RNA was quantiﬁed by measuring the absorption at
260 nm, a fraction was electrophoresed through 1.2%
agarose, 2.2 M formaldehyde gel to veriﬁed its integrity,
and stored at 80 C before use.
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Fig. 2. Mouse indentation tonometer reading plotted against the true
(transducer) IOP. Corresponding regression curve is shown with the
formula.
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phate dehydrogenase (GAPDH), as internal control,
expression of Bcl-2, Bax and P53 genes was analyzed
by semi-quantitative RT-PCR using a previously de-
scribed method (Li & Tseng, 1995). In brief, the ﬁrst-
strand cDNAs were synthesized from 1 lg of total
RNA using 50 units of MuLV reverse transcriptase, 20
units of RNAse inhibitor and 50 pmol of oligo(dT)16
as a primer in a 20 ll reaction solution at 42 C for 30
min. PCR ampliﬁcation of the ﬁrst-strand cDNAs was
performed by mixing 20 ll of the reverse transcription
reaction with 80 ll of buﬀer containing 2.5 units of
Taq DNA polymerase and 25 pmol of speciﬁc primer
pairs for mice Bcl-2, Bax, P53 and GADPH, designed
from published human gene sequences (Apte, Mattei,
& Olson, 1995; Cascino & Ruberti, 1995; Harlow et al.,
1985; Tso & Sun, 1985; Tsujimoto & Croce, 1986; Yang
& Korsmeyer, 1995). The PCR was performed in a Per-
kin–Elmer DNA Thermal Cycler 480 using the following
reaction sequence: ﬁrst denaturation for 2 min at 95 C
followed by 20–40 cycles of denaturation for 1 min
at 95 C, annealing for 1 min at 60 C and extension
for 1 min at 72 C; last extension for 7 min at 72 C.
Semi-quantitative RT-PCR was established by terminat-
ing reactions at intervals of 20, 24, 28, 32, 36 and 40
cycles for each primer pair to ensure that the PCR prod-
ucts formed were within the linear portion of the ampli-
ﬁcation curve. The RT-PCR products were visualized on
1.5% agarose gels electrophoresed in 1· TAE buﬀer
containing 0.5 lg/ml ethidium bromide. The ﬁdelity of
the RT-PCR product was veriﬁed by comparing the size
of the ampliﬁed products to the expected cDNA bands
and by sequencing the PCR products.Fig. 3. Comparison of IOP between experimental and control eyes. In
experimental eyes, the IOP was increased to approximately 1.5 times
above that of control eyes. Each data point and error bar represents
the mean ± SD IOP at each time point of measurement.3. Results
3.1. Tonometer calibration
Plotting the tonometer reading against the transducer
(true) IOP in enucleated eyes (n = 18) produced a regres-
sion curve as shown in Fig. 2, with a formula of
y =  13.908Ln(x) + 97.096 (R2 = 0.8753).
3.2. IOP measurement in wild-type live mouse
Measured IOP using the indentation tonometer in
conjunction with the derived regression curve in a strain
of non-glaucomatous mice (C57BL/6J, n = 6) was
11.2 ± 0.67 mm Hg (mean ± SD). This IOP range is con-
sistent with the reported norm for this particular mouse
strain (Avila et al., 2001; Sarinova et al., 2001), which
further conﬁrms the validity of our tonometer. IOP
did not diﬀer signiﬁcantly among normal mice
(p > 0.6) as would be expected within a single strain
(Sarinova, Sugiyama, & Martin, 2001).3.3. Elevated intraocular pressure
The mean IOP in animals under general anesthesia
and before treatment was 13 ± 1.8 mm Hg. Approxi-
mately 90% of treated eyes in this study had elevated
IOP. The mean IOP in the laser-treated eyes (n = 6)
was 20 ± 2.8 mm Hg, signiﬁcantly higher than that in
the control eyes at each time point during the ﬁrst four
weeks following laser treatment (p < 0.01), but with time,
the IOP decreased slightly through seven to eight weeks
after laser photocoagulation, the duration of this study
(Fig. 3). At eight weeks (n = 5), the IOP was 17 ± 2.2
mm Hg. There was no need to repeat laser treatment
after the ﬁrst session since an adequate elevation of
IOP was obtained and maintained over the study period.
3.4. Loss of retinal ganglion cells after laser
photocoagulation
The retinal ganglion cells retrogradely labeled by DiI
detected under confocal microscopy were quantiﬁed
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Fig. 5. Percentage of RGCs loss two and four weeks after elevation of
IOP. The number of RGCs was compared with the control, and the
diﬀerence was statistically signiﬁcant at two weeks (p < 0.05) and four
weeks (p < 0.01).
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with elevated IOP and control eyes. In the weeks follow-
ing laser photocoagulation, the density of RGCs in con-
trol (n = 5), two-week glaucomatous group (n = 5) and
four-week glaucomatous group (n = 5) is 77.2, 64.8
and 55.5 RGCs/lm2, respectively, and the percentage
of RGCs lost in the treated eyes with elevated IOP com-
pared to the untreated controls was 15.6 ± 3.4%. This
was a statistically signiﬁcant diﬀerence (p = 0.0345). At
four weeks, the death rate of RGCs was 27.3 ± 4.5%,
which was also a statistically signiﬁcant diﬀerence be-
tween control (n = 5) and glaucomatous groups(n = 5)
(p = 0.0072) (Figs. 4 and 5).Fig. 4. Representative photomicrographs showing retinal ganglion cell
loss two and four weeks after elevation of IOP. RGCs were retrograde-
labeled with DiI, and the number of RGCs in the normal eyes (A) were
compared with those in the experimental eyes (B and C), and the
diﬀerence was statistically signiﬁcant at both two weeks (B) and four
weeks (C). Scale bar = 20 lm.3.5. TUNEL staining
Apoptosis is suggested to be the possible mode of
RGC death in glaucoma. TUNEL-positive stained cells
were observed only in the ganglion cell layer (GCL).
Very few positive TUNEL cell staining was detected
(3 ± 1) in each section from control retinas (n = 3). At
two weeks post-laser (n = 3), the number of TUNEL-
positive cells in GCL in each section was increased sig-
niﬁcantly (25 ± 3, p < 0.01). Four weeks after laser
(n = 3), the TUNEL-positive cells in GCL remained at
increased levels compared to controls (18 ± 2, p < 0.01)
(Fig. 6).
3.6. Immunostaining for cleaved caspase-3
Caspase-3 is one of the key executioners of apoptosis,
being responsible either partially or totally for the pro-
teolytic cleavage of many key proteins in the apoptotic
process. Fig. 7 shows that caspase-3 positive cells were
observed in the ganglion cell layer (GCL) and rarely in
the inner nuclear layer (INL) in treated eyes with ele-
vated IOP. Caspase-3 positive cells were seldom found
in any retinal layer in the control eyes (n = 3) and more
frequently in the experimental group (n = 3) 12 ± 3 vs.
control group 2 ± 2 per section (Fig. 7).
3.7. Western blotting for Bcl-2 and Bax
The Bcl-2 family of genes is an important modulator
of apoptosis. Bcl-2 is a anti-apoptotic gene, whereas Bax
is proapoptotic. Recently it has been reported that reti-
nal ganglion cell survival and axon regeneration can be
supported through a Bcl-2-dependent mechanism
(Huang, Wu, & Chen, 2003). In this study, Bcl-2 and
Bax expression in the retina were used to assess the con-
trol of apoptosis in RGCs after laser treatment. The re-
sults showed that Bcl-2 expression in the control eyes
(n = 3) was higher than that in the photocoagulated eyes
(n = 3). On the contrary, Bax expression in control eyes
was less than that in experimental eyes. The ratio of Bcl-
2 to Bax showed that the net intensity in control group
Fig. 6. TUNEL-staining for cells in retinal ganglion cell layer. (A). Section from control retina. No TUNEL-positive cells (green) were observed in
the GCL. (B) Section from experimental retina two weeks after photocoagulation. TUNEL-positive cells were distributed in the GCL (arrow). Scale
bar, 20 lm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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(p < 0.05) (Fig. 8). These results are consistent with the
Bcl-2 family being involved in the upstream of the regu-
lation of apoptosis of RGCs in this model resulting in
RGC death.
3.8. RT-PCR
Representative semi-quantitive RT-PCR proﬁles of
mRNA expression of Bcl-2, Bax, Bad, Bak, p53, Fas,
ICE. Total RNA was extracted from control (n = 10)
and mouse retinas with elevated IOP two weeks follow-
ing laser photocoagulation (n = 10). RT-PCR was per-
formed using an equal amount of total RNA and was
analyzed at intervals of four cycles from 40 to 60 PCR
cycles, and with GADPH as an internal control. 100-
bp DNA ladder was run in parallel. The results showed
that the expression of anti-apoptotic gene Bcl-2 and
Bad, are higher in normal retinas compared with the
glaucomatous retinas. On the contrary, apoptotic genes
Bax, Bak, P53, Fas and ICE are higher in glaucomatous
groups (see Fig. 9).4. Discussion
The mouse model of elevated IOP is an advantageous
animal model for human glaucoma.
In this study, we have developed an acquired mouse
model of moderately elevated IOP in wild-type animals.
There is loss of RGCs in the treated eyes with character-
istics consistent with apoptosis as the mechanism of cell
death. Therefore, it appears to have great potential as an
animal model for glaucoma.
The mouse has been extensively studied in many
experimental ﬁelds because of the feasibility of using
transgenic or knockout technology, as well as the rela-
tive ease of handling and relatively low cost when com-pared with other mammals (John et al., 1999).
Moreover, the mouse eye has many structural similari-
ties to the human eye including a well-deﬁned trabecular
meshwork, Schlemns canal, ciliary body and vascular-
ized retina (John et al., 1999). However, due to the tech-
nical diﬃculty in non-invasively measuring IOP, an
acquired, chronic model of elevated IOP to study glau-
coma has not been established in mice. The development
of non-invasive tonometry in mice has opened the possi-
bility of developing and characterizing a mouse model of
elevated IOP. The non-invasive tonometer we have
developed and used for this study demonstrated an ade-
quate level of accuracy for this purpose. It has been cal-
ibrated with enucleated eyes since the small size of the
mouse globe places technical barriers that prevent place-
ment of a large enough needle to allow calibration with-
out distorting the anterior surface of the globe in vivo.
Although currently IOP measurement requires general
anesthesia, future developments may remove this step.
Furthermore short periods of anesthesia have been
shown to have no eﬀect on IOP in mice (Sarinova
et al., 2001). However, since each animal provides its
own control, it is unlikely that general anesthesia dimin-
ishes the study ﬁndings appreciably and this also limits
the possible impact of the loss of RGCs in aged non-
glaucomatous eyes that has been shown (Danias et al.,
2003a).
A mouse strain with elevated IOP has been described,
however in that model there are associated developmen-
tal anterior segment anatomic abnormalities potentially
aﬀecting the response to IOP elevation (John et al.,
1998). It is diﬃcult to compare the loss of RGCs from
this strain and from our model since that DBA/2 strain
did not show RGC loss until approximately 12 months
of age, with 64% of RGCs dying by the ﬁfteenth
month, even though IOP returned to lower, early (three
months of age) levels from months 12–18 (Danias et al.,
2003a).
Fig. 8. Western blot analysis for Bcl-2 and Bax. The control blots are
on the left, the experimental on the right. The Bcl-2/Bax ratio (optical
density) in control eyes was signiﬁcantly higher than that in experi-
mental group (p < 0.05).
Fig. 9. Representative semi-quantitive RT-PCR proﬁles of mRNA
expression of Bcl-2, Bax, Bad, Bak, p53, Fas, ICE. Total RNA was
extracted from control (C) and mouse retinas with elevated IOP for
two weeks (G). RT-PCR was performed using an equal amount of
total RNA and was analyzed at intervals of four cycles from 40 to 60
PCR cycles, and with GADPH as an internal control. 100-bp DNA
ladder was run in parallel.
Fig. 7. Immunostaining of caspase-3 in the retinas from control and
experimental eyes. Caspase-3-positive cells were observed in the
ganglion cell layer (GCL) but rarely in the inner nuclear layer (INL)
in eyes with elevated IOP (B) and (C) (arrow). Caspase-3 positive cells
were seldom observed in any retinal layer in the control eyes (A).
176 J. Ji et al. / Vision Research 45 (2005) 169–179Using the experience from the glaucoma model of ele-
vated IOP in rats that have been successfully established
and characterized, similar methods were used in this
study in mice. In the rat model of elevated IOP induced
by argon laser, it was shown that there was a twofold
IOP increase over baseline resulting in a 27–30% loss
of RGCs at two months (Mittag et al., 2000). Laser
photocoagulation was used to decrease aqueous outﬂow
and increase the IOP. This approach in mice successfully
produced elevated IOP in nearly 90% of treated eyes,
with a mean pressure of 23 mm Hg. Two and four weeks
after treatment, the number of RGCs had been reduced
by 15.6% and 27.3%, respectively, compared to normal,
untreated eyes. The ratio of DiI positive cells compared
to the number of nuclear stained cells closely approxi-mated the percentage of RGCs in the mouse ganglion
cell layer reported by Jeon, Strettoi, and Masland
(1998). Direct retrograde labeling was used recognizing
that this could be aﬀected by changes in retrograde
transport resulting from abnormal function in dying
RGCs. The similarity of these models is that there is a
modest elevation of IOP and chronic RGC death in
experimental eyes. However, there is a slight diﬀerence
in death rate and level of IOP between these two models.
For this mouse model, the power, duration, and number
of the laser applications are less than those in the rat be-
cause the smaller scale of the mouse globe. However,
our data suggest that this mouse model represents a
J. Ji et al. / Vision Research 45 (2005) 169–179 177valid model of elevated IOP with loss of RGCs. A recent
report of an alternative method of elevating IOP in mice
using laser to induce angle-closure also demonstrated
elevated IOP with a reduction of optic nerve cross-sec-
tional area, mean axon density, and total number of ax-
ons in the treated eyes at 12 weeks post-treatment
(Mabuchi et al., 2003). However, this technique requires
perforation of the cornea to ﬂatten the anterior chamber
prior to laser application. This microneedle perforation
could aﬀect ocular structures resulting in changes not re-
lated to elevated IOP alone. Additionally, if this model
is used with a non-invasive method of IOP measure-
ment, the perforation could aﬀect corneal structure
and the IOP measurement.
The mouse has distinct advantages compared to all
other models in that the mouse provides the potential
for rapid, inexpensive direct genetic manipulation una-
vailable in other species and this model uses wild-type
animals without other known ocular abnormalities.
Compared to other species, the elevation of IOP is more
modest in the mouse than in the rat or monkey, thus ap-
pears to more closely approximating the human glauco-
matous condition. In addition, only a single laser
treatment of lower energy is needed, unlike the other ac-
quired animal models. There is no evidence that the laser
application results in scarring of the limbal area that
could potentially alter subsequent tonometry.
The mouse model of elevated IOP is consistent with
the apoptotic RGC death hypothesis derived from hu-
man glaucoma studies.
Apoptosis is a genetically controlled form of cell
death that neurons undergo normal development as well
as disease (Nickells, 1999). There is evidence to suggest
that ganglion cells die in spontaneous or experimental
glaucoma by apoptosis (Quigley, Nickells, & Kerrigan,
1995; Wax, Tezel, & Edwards, 1998). Much of what
we know at the basic science level has been from the
study of experimental glaucoma in monkeys. In this pri-
mate model, early light and electron microscope obser-
vations of the RGCs indicated that dying cells
exhibited many of the features now known to be consist-
ent with apoptosis (Kerrigan, Zack, & Quigley, 1997).
Further evidence of apoptosis in experimental glaucoma
has been obtained by assaying ganglion cells for DNA
fragmentation. Monkeys exhibit at least 10 times more
TUNEL- positive RGCs in eyes with experimental glau-
coma than in control eyes (Kerrigan et al., 1997). More
recent studies on rats with elevated IOP have conﬁrmed
the TUNEL ﬁndings supporting apoptotic RGC death.
Additionally, studies have extended and conﬁrmed the
TUNEL ﬁndings by demonstrating multiple markers
of apoptotic degradation in RGC layer cells in human
retina from patients with glaucoma (Kerrigan et al.,
1997; Okisaka et al., 1997; Tatton et al., 2001; Wax
et al., 1998). The number of cells that are TUNEL-pos-
itive at any single time point exceed the number onewould predict based upon the total number of RGCs
lost during the course of this study. Although TUNEL
staining alone may not be speciﬁc for detecting apopto-
sis, combined with our further investigations, it is con-
sistent with apoptosis occurring. Our study showed
that TUNEL positive cells were present in the ganglion
cell layer in the experimental eyes and few positive cells
were found in control eyes or elsewhere in the retina.
Caspase-3 plays a central role as an eﬀector of DNA
fragmentation (Nickells, 1999). The increase in caspase-
3 in the treated eyes is consistent with increased RGC
death by apoptosis following IOP elevation. The Bcl-2
related group of proteins are critical modulators of
apoptosis. Studies have shown that overexpression of
Bcl-2 protects neurons against oxidative challenge (Law-
rence, Ho, Sun, & Steinberg, 1996). Bcl-2 can inhibit the
formation of permeability transition pore, which con-
trols cytochrome C release from mitochondria. How-
ever, Bax, induces the formation of new pores and
results in the cell death. Moreover, Bcl-2 can block acti-
vation of caspases and participates upstream from the
function of ICE/CED-3 protease and may inhibit apop-
tosis by preventing the post-translational activation of
protease. Our ﬁndings of increased proapoptotic factors
Bax in the eyes with elevated IOP again supports an in-
crease in apoptosis compared to the control eyes. Con-
versely, the reduced expression of the anti-apoptotic
factor Bcl-2 in the treated eyes is consistent with the pre-
vious ﬁndings. Our study suggests that apoptosis is
responsible for RGC loss in this mouse model of ele-
vated IOP by several diﬀerent techniques that are con-
sistent, thus supporting this model as a viable
glaucoma since apoptosis is strongly implicated as a
cause of RGC death in human glaucoma.5. Limitations of the present model and conclusions
There are limitations to this study. Using a new
tonometer introduces a source of error. However, the
device was calibrated using a pressure transducer, and
extreme accuracy, particularly given the recent contro-
versy in human tonometry, is not mandatory. Given
the correlation of normal mouse IOP with this tono-
meter and other existing devices and the marked diﬀer-
ences between the treated and control eyes, even if a
small amount of inaccuracy is introduced, it would not
impact the results appreciably. Additionally, although
this study presents multiple techniques consistent with
RGC death by apoptosis, additional studies will be
needed to determine if this is the only mechanism of cell
death present. It appears that at least some RGCs are
apoptotic in this model of elevated IOP based upon TU-
NEL staining and the changes in known eﬀectors of
apoptosis. Finally, the question of how representative
this model is compared to human glaucoma remains.
178 J. Ji et al. / Vision Research 45 (2005) 169–179Although the preliminary results presented are quite
encouraging, it remains for future investigations to con-
ﬁrm and deﬁne how closely the pathophysiology of this
mouse model of elevated IOP resembles human
glaucoma.
In conclusion, our study provides evidence for retinal
ganglion cell death in mice with elevated intraocular
pressure. Moreover, the loss of RGCs appears to be
due to apoptosis and is associated with axonal degener-
ation. Given these ﬁndings, it makes this mouse model a
viable tool in the investigations of glaucoma aimed at
slowing the progression of the neurodegenerative proc-
ess. Given the numerous candidate genes identiﬁed in
human glaucoma, there is no doubt that genetic and
molecular advances made possible by this model repre-
sent powerful techniques in the ongoing investigations
as to the mechanisms of glaucoma and gene function
in the future. The ultimate purpose of the development
of a mouse model of elevated IOP is to use it to better
understand and hopefully be more eﬀective in treating
and preventing human glaucoma.Acknowledgment
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